ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Letter Takes Two Weeks Off

August 28, 1987

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

July 20, 2012

In Brief: Search Committee Finds Prospects Uncertain About Election, Unwilling To Take Pay Cut

February 22, 1980

Young Investigators Hold Their Own

September 28, 1979

PhRMA’s New Ethics Code Prohibits Trinkets, Dinners; Speaking Fees Still OK.

July 11, 2008

FDA Proposes New Nonclinical Lab Regs

November 26, 1976